Avoro Capital Advisors Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Avoro Capital Advisors's estimated annual revenue is currently $3.3M per year.(i)
  • Avoro Capital Advisors's estimated revenue per employee is $155,000

Employee Data

  • Avoro Capital Advisors has 21 Employees.(i)
  • Avoro Capital Advisors grew their employee count by 5% last year.

Avoro Capital Advisors's People

NameTitleEmail/Phone
1
Managing Director - Investor Relations & MarketingReveal Email/Phone
2
DirectorReveal Email/Phone
3
Deputy Chief Compliance OfficerReveal Email/Phone
4
Partner, Chief Financial Officer & Chief Compliance OfficerReveal Email/Phone
5
DirectorReveal Email/Phone
6
Executive Assistant and Office ManagerReveal Email/Phone
7
Office Manager and Executive AssistantReveal Email/Phone
8
AnalystReveal Email/Phone
9
AnalystReveal Email/Phone
10
Hedge Fund ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is Avoro Capital Advisors?

Global life sciences firm focused on investments in biotechnology and specialty therapeutics.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Avoro Capital Advisors News

2022-04-17 - Institutional owners may take dramatic actions as CymaBay Therapeutics, Inc.'s (NASDAQ:CBAY) recent 13% drop adds to one-year losses

The company's largest shareholder is Avoro Capital Advisors LLC, with ownership of 12%. With 7.0% and 6.4% of the shares outstanding...

2022-03-30 - Avoro Ventures Announces Final Close of Inaugural Fund and ...

Avoro Ventures is an affiliated company of Avoro Capital Advisors, an SEC-registered investment manager based in New York City primarily focused...

2022-03-30 - Scribe Therapeutics to Participate in Upcoming Goldman ...

... institutional investors including Andreessen Horowitz, Avoro Ventures and Avoro Capital Advisors, OrbiMed Advisors, Perceptive Advisors,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M21-71%N/A
#2
$1.4M210%$3.5M
#3
N/A215%N/A
#4
$2.1M21-47%N/A
#5
$3.7M21-12%N/A